INS and Hypoglycemia: Blood glucose improved, allowing for a transition to long-acting insulin (Lantus), premeal insulin (Admelog), and an insulin sliding scale, which was transitioned to Admelog toward the end of admission due to intermittent episodes of hypoglycemia.